Cumberland Pharmaceuticals, Inc. (CPIX)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Sep 08, 16:00
6.80
+0.18
(+2.72%)
Pre-Market: 08:37
Cumberland Pharmaceuticals Total Liabilities (Quarterly) : 45.77M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.77M |
| March 31, 2026 | 49.69M |
| December 31, 2025 | 52.28M |
| September 30, 2025 | 40.10M |
| June 30, 2025 | 40.23M |
| March 31, 2025 | 41.60M |
| December 31, 2024 | 53.04M |
| September 30, 2024 | 52.28M |
| June 30, 2024 | 52.49M |
| March 31, 2024 | 54.32M |
| December 31, 2023 | 52.52M |
| September 30, 2023 | 52.10M |
| June 30, 2023 | 52.54M |
| March 31, 2023 | 53.42M |
| December 31, 2022 | 56.95M |
| September 30, 2022 | 52.29M |
| June 30, 2022 | 53.31M |
| March 31, 2022 | 55.90M |
| December 31, 2021 | 41.86M |
| September 30, 2021 | 40.92M |
| June 30, 2021 | 41.04M |
| March 31, 2021 | 46.47M |
| December 31, 2020 | 50.25M |
| September 30, 2020 | 48.17M |
| June 30, 2020 | 49.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 47.58M |
| December 31, 2019 | 54.78M |
| September 30, 2019 | 52.06M |
| June 30, 2019 | 53.86M |
| March 31, 2019 | 59.43M |
| December 31, 2018 | 59.10M |
| September 30, 2018 | 29.49M |
| June 30, 2018 | 30.77M |
| March 31, 2018 | 30.22M |
| December 31, 2017 | 31.38M |
| September 30, 2017 | 25.43M |
| June 30, 2017 | 21.31M |
| March 31, 2017 | 19.65M |
| December 31, 2016 | 23.52M |
| September 30, 2016 | 16.65M |
| June 30, 2016 | 13.51M |
| March 31, 2016 | 13.89M |
| December 31, 2015 | 15.10M |
| September 30, 2015 | 14.52M |
| June 30, 2015 | 14.21M |
| March 31, 2015 | 12.85M |
| December 31, 2014 | 14.65M |
| September 30, 2014 | 13.02M |
| June 30, 2014 | 12.74M |
| March 31, 2014 | 12.15M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 62.88M |
| Shareholders Equity (Quarterly) | 17.44M |
| Debt to Equity Ratio | 0.2703 |
| Current Ratio | 0.9559 |
| Net Debt Paydown Yield | 1.18% |